Sign Out
SOMPRAZ IV is indicated for: Gastric antisecretory treatment when the oral route is not possible, such as: gastroesophageal reflux disease in patients with esophagitis and/or severe symptoms of reflux; healing of gastric ulcers associated with NSAID therapy; prevention of gastric and duodenal ulcers associated with NSAID therapy, in patient at risk.
The short-term maintenance of haemostasis and prevention of rebleeding in patients following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers.
